AlzProtect's mission is to develop new bioactive molecules for the treatment of neurodegenerative diseases up to the first clinical trial in patients and partner with/license to a pharmaceutical company for further development and marketing.

Our molecules have innovative modes of action mainly based on the regulation of protein homeostasis. They are suitable for the treatment of tauopathies including well known Alzheimer’s disease (AD) and orphan disease Progressive Supranuclear Palsy (PSP).